ARCHIVES

Memorial’s Scher Warns FDA About Flaws In Provenge Data, Urges Not To Approve.

This article is from The Cancer Letter archive.

Vol. 33 No. 14 | April 13, 2007

Download PDF Visit The Full Archive

Related Articles

NCI advisors complete terms on board, Appelbaum’s term as BSA chairman ends.

July 23, 2004

Kennedy Agrees To Drop Dollar Limit In New Cancer Bill

January 11, 1980

Letter to the Editor

March 21, 2003

In Brief: NCAB To Hear NCOG Appeal; FDA Renege On New Toxicology Protocol, Holds Up INDs

April 24, 1981

Seattle Cancer Care Alliance Outpatient Clinic to Open – Jan. 19, 2001

June 7, 2021

Three Studies Test Oncotype DX In Breast and Colon Cancers

October 26, 2012